DENTSPLY SIRONA Inc
XRAY14.235USD
-0.065-0.45%
Market hours （ET）Quotes delayed by 15 min
2.84BMarket Cap
LossP/E TTM
More Details of DENTSPLY SIRONA Inc Company
DENTSPLY SIRONA Inc. is a manufacturer of professional dental products and technologies. It develops, manufactures, and markets a comprehensive solution offering including dental and oral health products as well as other consumable medical devices. Its Connected Technology Solutions segment includes the design, manufacture and sales of its dental technology and equipment products. Its Essential Dental Solutions segment includes the development, manufacture and sales of its value-added endodontic, restorative, and preventive consumable products and small equipment used in dental offices for the treatment of patients. Its Orthodontic and Implant Solutions segment includes the design, manufacture, and sales of its various digital implant systems and dental implant products, digital dentures and dental professional directed aligner solutions. Its Wellspect Healthcare segment includes the design, manufacture, and sales of its continence care solutions for both urinary and bowel management.
Company Info
Ticker SymbolXRAY
Company nameDENTSPLY SIRONA Inc
IPO dateAug 12, 1987
CEOMr. Daniel T. (Dan) Scavilla
Number of employees14000
Security typeOrdinary Share
Fiscal year-endAug 12
Address13320 Ballantyne Corporate Place
CityCHARLOTTE
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code28277-3607
Phone18445463722
Websitehttps://www.dentsplysirona.com/
Ticker SymbolXRAY
IPO dateAug 12, 1987
CEOMr. Daniel T. (Dan) Scavilla
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Gregory T. (Greg) Lucier
Mr. Gregory T. (Greg) Lucier
Independent Chairman of the Board
Independent Chairman of the Board
123.41K
+0.16%
Mr. Willie A. Deese
Mr. Willie A. Deese
Independent Director
Independent Director
57.28K
+0.24%
Ms. Janet S. Vergis
Ms. Janet S. Vergis
Independent Director
Independent Director
44.12K
+0.32%
Mr. Matthew E. Garth
Mr. Matthew E. Garth
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
43.45K
+1.00%
Mr. Clyde R. Hosein
Mr. Clyde R. Hosein
Independent Director
Independent Director
40.65K
+0.55%
Mr. Jonathan Jay Mazelsky
Mr. Jonathan Jay Mazelsky
Independent Director
Independent Director
33.93K
+0.83%
Mr. Brian T. Gladden
Mr. Brian T. Gladden
Independent Director
Independent Director
28.44K
+0.79%
Mr. Richard C. Rosenzweig
Mr. Richard C. Rosenzweig
Executive Vice President - Corporate Development, General Counsel, Secretary
Executive Vice President - Corporate Development, General Counsel, Secretary
25.40K
+2.40%
Mr. Michael J. (Mike) Barber, M.D.
Mr. Michael J. (Mike) Barber, M.D.
Independent Director
Independent Director
14.09K
+1.51%
Mr. Daniel T. (Dan) Scavilla
Mr. Daniel T. (Dan) Scavilla
President, Chief Executive Officer
President, Chief Executive Officer
14.09K
+1.51%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Gregory T. (Greg) Lucier
Mr. Gregory T. (Greg) Lucier
Independent Chairman of the Board
Independent Chairman of the Board
123.41K
+0.16%
Mr. Willie A. Deese
Mr. Willie A. Deese
Independent Director
Independent Director
57.28K
+0.24%
Ms. Janet S. Vergis
Ms. Janet S. Vergis
Independent Director
Independent Director
44.12K
+0.32%
Mr. Matthew E. Garth
Mr. Matthew E. Garth
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
43.45K
+1.00%
Mr. Clyde R. Hosein
Mr. Clyde R. Hosein
Independent Director
Independent Director
40.65K
+0.55%
Mr. Jonathan Jay Mazelsky
Mr. Jonathan Jay Mazelsky
Independent Director
Independent Director
33.93K
+0.83%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Implants & Prosthetics
158.00M
17.97%
CAD/CAM
134.00M
15.24%
Equipment & Instruments
101.00M
11.49%
Orthodontics
59.00M
6.71%
By RegionUSD
Name
Revenue
Proportion
Europe
362.00M
41.18%
United States
302.00M
34.36%
Rest of World
215.00M
24.46%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Implants & Prosthetics
158.00M
17.97%
CAD/CAM
134.00M
15.24%
Equipment & Instruments
101.00M
11.49%
Orthodontics
59.00M
6.71%
Shareholding Stats
Updated: Thu, May 29
Updated: Thu, May 29
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
10.35%
BlackRock Institutional Trust Company, N.A.
8.62%
First Eagle Investment Management, L.L.C.
7.25%
T. Rowe Price Associates, Inc.
6.91%
Fuller & Thaler Asset Management Inc.
6.06%
Other
60.81%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
10.35%
BlackRock Institutional Trust Company, N.A.
8.62%
First Eagle Investment Management, L.L.C.
7.25%
T. Rowe Price Associates, Inc.
6.91%
Fuller & Thaler Asset Management Inc.
6.06%
Other
60.81%
Shareholder Types
Shareholders
Proportion
Investment Advisor
48.98%
Investment Advisor/Hedge Fund
41.04%
Hedge Fund
9.45%
Research Firm
3.15%
Sovereign Wealth Fund
1.26%
Pension Fund
1.12%
Bank and Trust
0.57%
Individual Investor
0.41%
Family Office
0.12%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
1071
211.09M
105.92%
-31.61M
2025Q1
1100
209.97M
105.36%
-34.15M
2024Q4
1116
212.15M
106.59%
-31.74M
2024Q3
1108
218.82M
107.90%
-27.75M
2024Q2
1114
221.52M
106.70%
-12.09M
2024Q1
1147
216.71M
104.34%
-22.65M
2023Q4
1167
223.33M
105.42%
-4.04M
2023Q3
1198
213.44M
100.81%
-18.52M
2023Q2
1222
214.75M
101.06%
-24.43M
2023Q1
1224
223.77M
105.31%
-22.49M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
20.63M
10.35%
+545.88K
+2.72%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
17.18M
8.62%
+68.88K
+0.40%
Mar 31, 2025
First Eagle Investment Management, L.L.C.
14.44M
7.25%
-61.43K
-0.42%
Mar 31, 2025
T. Rowe Price Associates, Inc.
13.77M
6.91%
+1.40M
+11.32%
Mar 31, 2025
Fuller & Thaler Asset Management Inc.
12.08M
6.06%
+538.53K
+4.67%
Mar 31, 2025
Lazard Asset Management, L.L.C.
9.36M
4.7%
+1.32M
+16.38%
Mar 31, 2025
Cooke & Bieler, L.P.
9.16M
4.59%
-15.57K
-0.17%
Mar 31, 2025
Nuance Investments, LLC
8.99M
4.51%
-4.56M
-33.65%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
6.96M
3.49%
+105.12K
+1.53%
Mar 31, 2025
State Street Global Advisors (US)
6.73M
3.38%
-32.26K
-0.48%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
3D Printing ETF
4.45%
Brandes US Small-Mid Cap Value ETF
2.26%
SPDR S&P Health Care Equipment ETF
1.8%
Royce Quant Small-Cap Quality Value ETF
0.71%
VictoryShares Hedged Equity Income ETF
0.53%
AGF US Market Neutral Anti-Beta Fund
0.49%
WisdomTree U.S. SmallCap Dividend Fund
0.49%
Invesco NASDAQ Future Gen 200 ETF
0.45%
Federated Hermes MDT Large Cap Value ETF
0.3%
SPDR S&P Kensho New Economies Composite ETF
0.26%
View more
3D Printing ETF
Proportion4.45%
Brandes US Small-Mid Cap Value ETF
Proportion2.26%
SPDR S&P Health Care Equipment ETF
Proportion1.8%
Royce Quant Small-Cap Quality Value ETF
Proportion0.71%
VictoryShares Hedged Equity Income ETF
Proportion0.53%
AGF US Market Neutral Anti-Beta Fund
Proportion0.49%
WisdomTree U.S. SmallCap Dividend Fund
Proportion0.49%
Invesco NASDAQ Future Gen 200 ETF
Proportion0.45%
Federated Hermes MDT Large Cap Value ETF
Proportion0.3%
SPDR S&P Kensho New Economies Composite ETF
Proportion0.26%
Dividend
A total of
526.00M
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Feb 28, 2025
XRAY.NB Interim Cash Dividend of gross USD 0.16 paid on Apr 11, 2025 going ex on Mar 28, 2025
Mar 28, 2025
Apr 11, 2025
Mar 28, 2025
Dec 13, 2024
XRAY.NB Final Cash Dividend of gross USD 0.16 paid on Jan 10, 2025 going ex on Dec 27, 2024
Dec 27, 2024
Jan 10, 2025
Dec 27, 2024
Aug 01, 2024
XRAY.NB Interim Cash Dividend of gross USD 0.16 paid on Oct 11, 2024 going ex on Sep 27, 2024
Sep 27, 2024
Oct 11, 2024
Sep 27, 2024
May 22, 2024
XRAY.NB Interim Cash Dividend of gross USD 0.16 paid on Jul 12, 2024 going ex on Jun 28, 2024
Jun 28, 2024
Jul 12, 2024
Jun 28, 2024
Feb 29, 2024
XRAY.NB Interim Cash Dividend of gross USD 0.16 paid on Apr 12, 2024 going ex on Mar 27, 2024
Mar 29, 2024
Apr 12, 2024
Mar 27, 2024
Dec 21, 2023
XRAY.NB Final Cash Dividend of gross USD 0.14 paid on Jan 12, 2024 going ex on Dec 28, 2023
Dec 29, 2023
Jan 12, 2024
Dec 28, 2023
Aug 11, 2023
XRAY.NB Interim Cash Dividend of gross USD 0.14 paid on Oct 13, 2023 going ex on Sep 28, 2023
Sep 29, 2023
Oct 13, 2023
Sep 28, 2023
May 24, 2023
XRAY.NB Interim Cash Dividend of gross USD 0.14 paid on Jul 14, 2023 going ex on Jun 29, 2023
Jun 30, 2023
Jul 14, 2023
Jun 29, 2023
Mar 06, 2023
XRAY.NB Interim Cash Dividend of gross USD 0.14 paid on Apr 14, 2023 going ex on Mar 30, 2023
Mar 31, 2023
Apr 14, 2023
Mar 30, 2023
Dec 15, 2022
XRAY.NB Final Cash Dividend of gross USD 0.125 paid on Jan 13, 2023 going ex on Dec 29, 2022
Dec 30, 2022
Jan 13, 2023
Dec 29, 2022
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
